Please wait a minute...
Reviews in Cardiovascular Medicine  2021, Vol. 22 Issue (3): 807-816     DOI: 10.31083/j.rcm2203087
Special Issue: State-of-the-Art Cardiovascular Medicine in Asia 2021
Review Previous articles | Next articles
Sudden cardiac death in patients with myocardial infarction: 1.5 primary prevention
Yun-Tao Feng1, Xiang-Fei Feng2, *()
1Dalian Medical University, 116044 Dalian, Liaoning, China
2Department of Cardiology, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, 200092 Shanghai, China
Download:  PDF(1775KB)  ( 258 ) Full text   ( 15 )
Export:  BibTeX | EndNote (RIS)      
Abstract:
Sudden cardiac death (SCD) is one of the most common causes of death in the world. Coronary heart disease (CHD) is the root cause of most patients with SCD, and myocardial infarction (MI) is the main cause of SCD among all types of CHD. Early identification of high-risk patients after an MI, and the application of related prevention strategies and disease-specific treatments will be the key to reduce SCD. The mechanism of SCD after MI varies over time, and the relevant risk prediction indicators are also dynamic and different. In the existing guidelines for MI patients, the static and slightly single stratification of primary (PP) and secondary (SP) prevention has significant room for improvement. The 1.5 primary prevention (1.5PP) is defined as patients with PP who also had the following risk factors: non-sustained ventricular tachycardia (NSVT), frequent premature ventricular contractions (PVCs), severe heart failure (left ventricular ejection fraction, LVEF <25%), and syncope or pre-syncope. The emergence of 1.5PP has provided a new method for the stratification and management of SCD after an MI.
Key words:  Sudden cardiac death      Myocardial infarction      Implantable cardioverter-defibrillator      Primary prevention      Secondary prevention      1.5 primary prevention     
Submitted:  13 June 2021      Revised:  22 July 2021      Accepted:  26 July 2021      Published:  24 September 2021     
*Corresponding Author(s):  Xiang-Fei Feng     E-mail:  fengxiangfei@xinhuamed.com.cn

Cite this article: 

Yun-Tao Feng, Xiang-Fei Feng. Sudden cardiac death in patients with myocardial infarction: 1.5 primary prevention. Reviews in Cardiovascular Medicine, 2021, 22(3): 807-816.

URL: 

https://rcm.imrpress.com/EN/10.31083/j.rcm2203087     OR     https://rcm.imrpress.com/EN/Y2021/V22/I3/807

[1] Anthony G. Matta, Vanessa Nader, Jerome Roncalli. Management of myocardial infarction with Nonobstructive Coronary Arteries (MINOCA): a subset of acute coronary syndrome patients[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 625-634.
[2] Rasha Kaddoura, Salah Elbdri. Current evidence in the diagnosis and management of cardiogenic shock complicating acute coronary syndrome[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 691-715.
[3] Leonardo De Luca, Luca Paolucci, Annunziata Nusca, Rita Lucia Putini, Fabio Mangiacapra, Enrico Natale, Gian Paolo Ussia, Furio Colivicchi, Francesco Grigioni, Francesco Musumeci, Domenico Gabrielli. Current management and prognosis of patients with recurrent myocardial infarction[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 731-740.
[4] César Jiménez-Méndez, Pablo Díez-Villanueva, Fernando Alfonso. Non-ST segment elevation myocardial infarction in the elderly[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 779-786.
[5] Eduardo Matos Vilela, Ricardo Ladeiras-Lopes, Ana João, Susana Torres, José Ribeiro, Lilibeth Campos, Fátima Miranda, José Pedro Nunes, Madalena Teixeira, Ricardo Fontes-Carvalho. Cardiac rehabilitation in elderly myocardial infarction survivors: focus on circulatory power[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 903-910.
[6] Florina Caruntu, Diana Aurora Bordejevic, Mirela Cleopatra Tomescu, Ioana Mihaela Citu. Clinical characteristics and outcomes in acute myocardial infarction patients aged ≥65 years in Western Romania[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 911-918.
[7] Marco Schiavone, Federica Sabato, Cecilia Gobbi, Marialessia Denora, Lucrezia Zanchi, Alessio Gasperetti, Giovanni B. Forleo. Atrioventricular and intraventricular blocks in the setting of acute coronary syndromes: a narrative review[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 287-294.
[8] Eyad Abuelgasim, Suleyman Shah, Biyaser Abuelgasim, Nikita Soni, Ashvin Thomas, Mustafa Elgasim, Amer Harky. Clinical overview of diabetes mellitus as a risk factor for cardiovascular death[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 301-314.
[9] Florina Căruntu, Diana Aurora Bordejevic, Bogdan Buz, Alexandru Gheorghiu, Mirela Cleopatra Tomescu. Independent predictors of in-hospital and 1-year mortality rates in octogenarians with acute myocardial infarction[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 489-497.
[10] Akshay Kumar, Dor Mordehay Avishay, Calvin Richard Jones, Juber Dastagir Shaikh, Roopvir Kaur, Michael Aljadah, Asim Kichloo, Nimisha Shiwalkar, Suresh Keshavamurthy. Sudden cardiac death: epidemiology, pathogenesis and management[J]. Reviews in Cardiovascular Medicine, 2021, 22(1): 147-158.
[11] Byung Woo Yoon, Ji Yeon Hong. Sildenafil-triggered multi-culprit ST-segment elevation myocardial infarction: a case report[J]. Reviews in Cardiovascular Medicine, 2021, 22(1): 185-189.
[12] Khalid Bin Waleed, Gary Tse, Yong-Kang Lu, Chang-Nong Peng, Hong Tu, Li-Gang Ding, Yun-Long Xia, Shu-Lin Wu, Xin-Tao Li, Hou-Qing Zhou, Qi-Ying Chen, Ai-Mei Sun, Afrasyab Altaf, Jun-Lei Chang, Li-Li Wang. Trimethylamine N-oxide is associated with coronary atherosclerotic burden in non-ST-segment myocardial infarction patients: SZ-NSTEMI prospective cohort study[J]. Reviews in Cardiovascular Medicine, 2021, 22(1): 231-238.
[13] Ajay K. Mahenthiran, Ashorne K. Mahenthiran, Jo Mahenthiran. Cardiovascular system and COVID-19: manifestations and therapeutics[J]. Reviews in Cardiovascular Medicine, 2020, 21(3): 399-409.
[14] Takeshi Tsuda, Kristi K. Fitzgerald, Joel Temple. Sudden cardiac death in children and young adults without structural heart disease: a comprehensive review[J]. Reviews in Cardiovascular Medicine, 2020, 21(2): 205-216.
[15] En Chen, Wei Cai, Danqing Hu, Lianglong Chen. Effect of remote ischemic preconditioning in patients with STEMI during primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials[J]. Reviews in Cardiovascular Medicine, 2020, 21(1): 103-112.
No Suggested Reading articles found!